Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yozo Mitsui

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Journal of Visualized Experiments : Jove|September 30, 2016
Pre-clinical Orthotopic Murine Model of Human Prostate CancerVarahram Shahryari, Hannah Nip, Sharanjot Saini, et al.
BMC Cancer|December 3, 2015
CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinomaYozo Mitsui, Inik Chang, Shinichiro Fukuhara, et al.
Oncotarget|December 20, 2014
DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cellsShinichiro Fukuhara, Inik Chang, Yozo Mitsui, et al.
Oncotarget|January 1, 2017
Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and CaucasiansMarisa Shiina, Yutaka Hashimoto, Taku Kato, et al.
Oncotarget|February 4, 2017
The role of miR-24 as a race related genetic factor in prostate cancerYutaka Hashimoto, Marisa Shiina, Taku Kato, et al.
Oncotarget|June 4, 2015
Functional role of DNA mismatch repair gene PMS2 in prostate cancer cellsShinichiro Fukuhara, Inik Chang, Yozo Mitsui, et al.
Oncotarget|May 21, 2016
Functional role and tobacco smoking effects on methylation of CYP1A1 gene in prostate cancerYozo Mitsui, Inik Chang, Taku Kato, et al.
Oncotarget|October 23, 2018
Correction: Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer <i>via</i> caspase-1 activationInik Chang, Yozo Mitsui, Seul Ki Kim, et al.
Oncotarget|April 8, 2017
Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activationInik Chang, Yozo Mitsui, Seul Ki Kim, et al.
Molecular Cancer Research : MCR|March 1, 2017
Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal CarcinomaYozo Mitsui, Hiroaki Shiina, Taku Kato, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Journal of Visualized Experiments : Jove|September 30, 2016
Pre-clinical Orthotopic Murine Model of Human Prostate CancerVarahram Shahryari, Hannah Nip, Sharanjot Saini, et al.
BMC Cancer|December 3, 2015
CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinomaYozo Mitsui, Inik Chang, Shinichiro Fukuhara, et al.
Oncotarget|December 20, 2014
DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cellsShinichiro Fukuhara, Inik Chang, Yozo Mitsui, et al.
Oncotarget|January 1, 2017
Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and CaucasiansMarisa Shiina, Yutaka Hashimoto, Taku Kato, et al.
Oncotarget|February 4, 2017
The role of miR-24 as a race related genetic factor in prostate cancerYutaka Hashimoto, Marisa Shiina, Taku Kato, et al.
Oncotarget|June 4, 2015
Functional role of DNA mismatch repair gene PMS2 in prostate cancer cellsShinichiro Fukuhara, Inik Chang, Yozo Mitsui, et al.
Oncotarget|May 21, 2016
Functional role and tobacco smoking effects on methylation of CYP1A1 gene in prostate cancerYozo Mitsui, Inik Chang, Taku Kato, et al.
Oncotarget|October 23, 2018
Correction: Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer <i>via</i> caspase-1 activationInik Chang, Yozo Mitsui, Seul Ki Kim, et al.
Oncotarget|April 8, 2017
Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activationInik Chang, Yozo Mitsui, Seul Ki Kim, et al.
Molecular Cancer Research : MCR|March 1, 2017
Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal CarcinomaYozo Mitsui, Hiroaki Shiina, Taku Kato, et al.
Pageof 7